Hit Co., Ltd. (TYO:378A)
Japan flag Japan · Delayed Price · Currency is JPY
2,078.00
-34.00 (-1.61%)
Aug 1, 2025, 3:30 PM JST

Ligand Pharmaceuticals Revenue

In the fiscal year ending June 30, 2024, Hit Co., Ltd. had annual revenue of 4.12B JPY with 20.00% growth. Hit Co., Ltd. had revenue of 925.00M in the quarter ending March 31, 2025.

Revenue
4.12B
Revenue Growth
+20.00%
P/S Ratio
3.14
Revenue / Employee
49.66M
Employees
83
Market Cap
12.95B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20244.12B687.00M20.00%
Jun 30, 20233.44B833.90M32.06%
Jun 30, 20222.60B699.94M36.82%
Jun 30, 20211.90B-223.26M-10.51%
Jun 30, 20202.12B-76.74M-3.49%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SoftBank Group7,243.75B
NTT, Inc.13.70T
SoftBank6,544.35B
KDDI Corporation5,917.95B
LY Corporation1,917.48B
Toho Co., Ltd.312.07B
Nippon Television Holdings461.92B
TBS Holdings,Inc.406.70B
Revenue Rankings